share_log

Together With Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

Together With Siemens Healthineers, Varian Showcases Commitment to Embracing Innovation and Enhancing Outcomes at ESTRO 2024

瓦里安與西門子 Healthineers 一起在 ESTRO 2024 上展示了對擁抱創新和提高成果的承諾
PR Newswire ·  05/02 03:00

PALO ALTO, Calif., May 2, 2024 /PRNewswire/ -- Varian, a Siemens Healthineers company, will showcase its ongoing commitment to embracing innovation and enhancing outcomes for cancer care teams and their patients at this year's 2024 European Society for Radiation Oncology (ESTRO) annual meeting, which will take place from May 3 to 7 in Glasgow, Scotland.

加利福尼亞州帕洛阿爾託,2024年5月2日 /PRNewswire/ — 西門子Healthineers旗下的瓦里安將在今年5月3日至7日在蘇格蘭格拉斯哥舉行的2024年歐洲放射腫瘤學會(ESTRO)年會上展示其對擁抱創新和提高癌症治療團隊及其患者療效的持續承諾。

With over 24 million new cancer cases expected by 2030, accessible, high-quality cancer treatment is crucial to improving patient outcomes1. Radiotherapy is an integral part of therapeutic treatments for approximately 50% of the patients diagnosed with cancer, yet many countries have inadequate availability of radiotherapy treatment2. Varian is working in collaboration with healthcare providers to change that statistic by creating innovative and integrated solutions to help bring treatment options to those communities who need it most.

到2030年,預計新增癌症病例將超過2400萬例,可獲得的高質量癌症治療對於改善患者預後至關重要1。對於大約50%的癌症診斷患者,放射療法是治療不可或缺的一部分,但是許多國家的放射療法治療供應不足2。瓦里安正在與醫療保健提供商合作,通過創建創新的綜合解決方案來改變這一統計數據,爲最需要的社區提供治療選擇。

"As part of Siemens Healthineers, Varian is in a unique position to develop cutting-edge products and solutions that bridge the care gap globally," remarked Arthur Kaindl, Head of Varian. "By combining the expertise of the leading imaging and radiotherapy companies, we have the ability to achieve much more than any individual cancer care company by driving connection throughout the entire care continuum."

瓦里安負責人亞瑟·凱恩德爾表示:“作爲西門子Healthineers的一部分,瓦里安在開發彌合全球醫療差距的尖端產品和解決方案方面處於獨特的地位。”“通過結合領先的成像和放射治療公司的專業知識,通過推動整個護理過程中的連接,我們有能力取得比任何一家癌症護理公司都要多的成就。”

At the ESTRO meeting, Varian will present a range of solutions that will enhance the care continuum, including:

在 ESTRO 會議上,瓦里安將介紹一系列可增強護理連續性的解決方案,包括:

  • HyperSight imaging solution is now available as an optional feature on Ethos, Halcyon, Edge, and TrueBeam radiotherapy platforms. Delivering a revolution in resolution, HyperSight imaging offers superior image quality, enhanced contrast, and faster image acquisition compared to conventional Varian linear-accelerator-based imaging systems.
  • ARIA CORE, Varian's next-generation oncology management solution, is designed to integrate oncology workflows across cancer care disciplines. ARIA CORE aims to provide care teams with actionable analytics and holistic patient insights for more personalized care and treatment.
  • DirectSetup Notes is a new, advanced tool enabled with syngo CT VB10 on Siemens Healthineers CT simulators SOMATOM go.Sim and SOMATOM go.Open Pro. DirectSetup Notes enables RT staff to document patient setup information during simulation directly on the CT scanner's tablet, allowing RT staff to spend more time with their patients. It then transfers all recorded information directly to ARIA CORE or other oncology information systems for future reference and analysis.
  • MAGNETOM Free.Max RT Edition is the latest addition to the Siemens Healthineers Magnetic Resonance (MR) imaging portfolio for personalized radiation therapy. This new MR system allows users to experience a new level of anatomical detail, increased flexibility, and unconventional affordability due to its lower total cost of ownership than traditional MR systems.
  • The latest version of the IDENTIFY patient motion management system provides users with upgrades designed to optimize performance, increase workflow efficiency, and integrate with treatment delivery, including surface-guided radiotherapy. The IDENTIFY system aims to provide fast, highly precise motion management during the delivery of a wide range of treatments and techniques.
  • HyperSight 成 現已作爲可選功能在Ethos、Halcyon、Edge和TrueBeam放射治療平台上提供。與基於瓦里安線性加速器的傳統成像系統相比,HyperSight 成像帶來了分辨率的革命,提供了卓越的圖像質量、增強的對比度和更快的圖像採集速度。
  • 詠歎調核心, 瓦里安的下一代腫瘤學管理解決方案旨在整合跨癌症治療學科的腫瘤學工作流程。ARIA CORE旨在爲護理團隊提供切實可行的分析和全面的患者見解,以實現更加個性化的護理和治療。
  • 直接安裝注意事項 是一款新的高級工具,在西門子 Healthineers CT 模擬器 SOMATOM go.sim 和 SOMATOM GO.Open Pro 上支持 syngo CT VB10。DirectSetup Notes使RT工作人員能夠直接在CT掃描儀的平板電腦上記錄模擬期間的患者設置信息,從而使RT工作人員有更多的時間陪伴患者。然後,它將所有記錄的信息直接傳輸到ARIA CORE或其他腫瘤學信息系統,以供將來參考和分析。
  • MAGNETOM Free.Max RT 版 是西門子Healthineers磁共振(MR)個性化放射治療成像產品組合的最新成員。由於其總擁有成本低於傳統 MR 系統,這種新的 MR 系統使用戶能夠體驗到更高水平的解剖細節、更高的靈活性和非常規的可負擔性。
  • 最新版本的 識別患者運動管理 系統爲用戶提供旨在優化性能、提高工作流程效率並與治療交付(包括表面引導放射治療)相集成的升級。IDENTIFY 系統旨在在各種治療和技術的交付過程中提供快速、高精度的運動管理。

Varian is committed to generating evidence that can help improve patient outcomes and expand access to care. This commitment is evident through its efforts to elevate the standard of care, which will be showcased at ESTRO through numerous oral, panel, customer use cases, and poster presentations. These presentations, which include products such as Ethos and HyperSight imaging, will contribute to the growing body of clinical evidence and data across various treatment domains, further reinforcing Varian's dedication to enhancing patient care.

瓦里安致力於收集有助於改善患者預後和擴大獲得醫療服務的證據。這一承諾體現在其爲提高護理標準所做的努力中,ESTRO將通過大量口頭、小組討論、客戶用例和海報演示來展示這一點。這些演示包括 Ethos 和 HyperSight 成像等產品,將爲越來越多的不同治療領域的臨床證據和數據做出貢獻,進一步強化瓦里安對加強患者護理的承諾。

VARIAN, HYPERSIGHT, ETHOS, HALCYON, EDGE, TRUEBEAM, ARIA CORE, and IDENTIFY are trademarks of Varian Medical Systems, Inc., pending or registered U.S. Pat. & Tm. Off. MAGNETOM Free.Max, SOMATOM go.Sim, and SOMATOM go.Open Pro are trademarks of Siemens Healthcare GmbH registered U.S. Pat. & Tm. Off.

瓦里安、HYPERSIGHT、ETHOS、HALCYON、EDGE、TRUEBEAM、ARIA CORE 和 IDENTIFY 是瓦里安醫療系統公司的商標,正在申請或註冊於美國 Pat. & Tm.關閉。MAGNETOM Free.Max、SOMATOM GO.SIM 和 SOMATOM GO.Open Pro 是西門子醫療保健有限公司在美國註冊的商標。關閉。

About Varian
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy, to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit

關於瓦里安
在西門子健康集團旗下的瓦里安,我們設想一個不用擔心癌症的世界。75 年來,瓦里安開發、構建和交付了創新的技術和解決方案,幫助全球醫療服務提供者每年治療數百萬患者。如今,作爲西門子Healthineers的一家公司,我們爲癌症護理之旅的每一步——從篩查到存活,提供支持。從先進的成像和放射治療,到全面的軟件和服務,再到介入放射學,我們正在利用我們視角的力量,同時進行臨床研究,以創建更高效、更個性化的護理途徑。因爲,對於世界各地的癌症患者來說,他們的鬥爭就是我們的鬥爭。欲了解更多信息,請訪問

Press Contact
Kristin Corey
Varian Corporate Communications
[email protected]

新聞聯繫人
克里斯汀·科裏
瓦里安企業傳播
[電子郵件保護]

1 Cancer Tomorrow | IARC -
2 M Abdel-Wahab, et al. JCO Global Oncol. 2021(7):827-842.

1 明天的癌症 | IARC-
2 M Abdel-Wahab 等JCO Global Oncol. 2021 (7): 827-842.

SOURCE Varian

來源 Varian

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論